FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eileen Barry

Research Profile

Chemicals & Drugs

Living Beings

Co-author Network

Publications

TOP 3
Eileen M Barry; Alessio Fasano; Karen L Kotloff; Marcela F Pasetti; Marcelo B Sztein; Myron M Levine
Progress and pitfalls in Shigella vaccine research.
Christina S Faherty; David Rasko; Julia C Redman; Eileen M Barry; James P Nataro
Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure.
Mark E Marohn; Araceli E Santiago; Kari Ann Shirey; Stefanie N Vogel; Michael Lipsky; Eileen M Barry
Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eileen Barry (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eileen M Barry; Alessio Fasano; Karen L Kotloff; Marcela F Pasetti; Marcelo B Sztein; Myron M Levine
Progress and pitfalls in Shigella vaccine research.
Nature reviews. Gastroenterology & hepatology 2013;10(4):245-55.
2012: Christina S Faherty; David Rasko; Julia C Redman; Eileen M Barry; James P Nataro
Shigella flexneri effectors OspE1 and OspE2 mediate induced adherence to the colonic epithelium following bile salts exposure.
Molecular microbiology 2012;85(1):107-21.
2012: Mark E Marohn; Araceli E Santiago; Kari Ann Shirey; Stefanie N Vogel; Michael Lipsky; Eileen M Barry
Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis.
Infection and immunity 2012;80(7):2390-401.
2012: Christina Faherty; Alessio Fasano; Jill Harper; James B Kaper; Eileen M Barry; Terez Shea-Donohue; James P Nataro
Chromosomal and plasmid-encoded factors of Shigella flexneri induce secretogenic activity ex vivo.
PloS one 2012;7(11):e49980.
2011: Tao Wu; Christen Grassel; Myron M Levine; Eileen M Barry
Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit.
Infection and immunity 2011;79(12):4912-22.
2011: Satoshi Ohtake; Araceli E Santiago; Atul Saxena; Eileen M Barry; David Lechuga-Ballesteros; Russell A Martin; Vu Truong-Le
Formulation and stabilization of Francisella tularensis live vaccine strain.
Journal of pharmaceutical sciences 2011;100(8):3076-87.
2011: Mauricio J Farfán; Cecilia S Toro; Eileen M Barry; James P Nataro
Shigella enterotoxin-2 is a type III effector that participates in Shigella-induced interleukin 8 secretion by epithelial cells.
FEMS immunology and medical microbiology 2011;61(3):332-9.
2011: Douglas S Reed; Le'kneitah Smith; Anita Trichel; Kelly Stefano Cole; Tammy Dunsmore; Luis A Ortiz; Eileen M Barry
Pneumonic tularemia in rabbits resembles the human disease as illustrated by radiographic and hematological changes after infection.
PloS one 2011;6(9):e24654.
2010: Leah E Cole; Michelle H W Laird; Anna Seekatz; Araceli Santiago; Zhaozhao Jiang; Eileen M Barry; Kari Ann Shirey; Katherine A Fitzgerald; Stefanie N Vogel
Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.
Journal of leukocyte biology 2010;87(2):275-81.
2009: Eileen M Barry; Leah E Cole; Araceli E Santiago
Vaccines against tularemia.
Human vaccines 2009;5(12):832-8.
2009: J S Hill Gaston; Robert D Inman; Edward T Ryan; Malabi M Venkatesan; Eileen M Barry; Thomas L Hale; A Louis Bourgeois; Richard I Walker
Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis.
Vaccine 2009;27(40):5432-4.
2009: K K Baker; Myron M Levine; J Morison; A Phillips; Eileen M Barry
CfaE tip mutations in enterotoxigenic Escherichia coli CFA/I fimbriae define critical human intestinal binding sites.
Cellular microbiology 2009;11(5):742-54.
2009: Araceli E Santiago; Leah E Cole; Augusto A. Franco-Mora; Stefanie N Vogel; Myron M Levine; Eileen M Barry
Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.
Vaccine 2009;27(18):2426-36.
2009: Marcela F Pasetti; Karina Ramirez; Aldo Resendiz-Albor; Jeffrey Ulmer; Eileen M Barry; Myron M Levine
Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
Journal of virology 2009;83(6):2789-94.
2008: Leah E Cole; Araceli Santiago; Eileen M Barry; Tae Jin Kang; Kari Ann Shirey; Zachary J Roberts; Karen L Elkins; Alan S Cross; Stefanie N Vogel
Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(10):6885-91.
2008: Karina Ramirez; Eileen M Barry; Jeffrey Ulmer; Richard Stout; James Szabo; Timothy Scott Manetz; Myron M Levine; Marcela F Pasetti
Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.
Human gene therapy 2008;19(5):522-31.
2007: Marcela F Pasetti; A Resendiz-Albor; K Ramirez; R Stout; M Papania; Robert J Adams; Fernando P Polack; brian ward; David Burt; Sophie Chabot; Jeffrey Ulmer; Eileen M Barry; Myron M Levine
Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
Clinical pharmacology and therapeutics 2007;82(6):672-85.
2007: Karen L Kotloff; Jakub K Simon; Marcela F Pasetti; Marcelo B Sztein; Stacey L Wooden; Sofie Livio; James P Nataro; William C Blackwelder; Eileen M Barry; William D Picking; Myron M Levine
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media.
Human vaccines 2007;3(6):268-75.
2007: Leah E Cole; Kari Ann Shirey; Eileen M Barry; Araceli Santiago; Prasad Rallabhandi; Karen L Elkins; Adam C Puche; Suzanne M Michalek; Stefanie N Vogel
Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.
Infection and immunity 2007;75(8):4127-37.
2007: Myron M Levine; Karen L Kotloff; Eileen M Barry; Marcela F Pasetti; Marcelo B Sztein
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.
Nature reviews. Microbiology 2007;5(7):540-53.
2006: Alejandra V E Capozzo; Karina Ramírez; John M Polo; Jeffrey Ulmer; Eileen M Barry; Myron M Levine; Marcela F Pasetti
Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5671-81.
2006: Eileen M Barry; Jin Wang; Tao Wu; Tamar Davis; Myron M Levine
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Vaccine 2006;24(18):3727-34.
2005: Man Ki Song; Christofer J Vindurampulle; Alejandra V E Capozzo; Jeffrey Ulmer; John M Polo; Marcela F Pasetti; Eileen M Barry; Myron M Levine
Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Journal of virology 2005;79(15):9854-61.
2004: Karen L Kotloff; Marcela F Pasetti; Eileen M Barry; James P Nataro; Steven Wasserman; Marcelo B Sztein; William D Picking; Myron M Levine
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
The Journal of infectious diseases 2004;190(10):1745-54.
2004: Christofer J Vindurampulle; Lilian Cuberos; Eileen M Barry; Marcela F Pasetti; Myron M Levine
Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
Vaccine 2004;22(27-28):3744-50.
2003: Marcela F Pasetti; Eileen M Barry; Genevieve A Losonsky; Mahender Singh; Sandra Medina-Moreno; John M Polo; Jeffrey Ulmer; Harriet Robinson; Marcelo B Sztein; Myron M Levine
Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Journal of virology 2003;77(9):5209-17.
2003: Zeev Altboum; Myron M Levine; James E Galen; Eileen M Barry
Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain.
Infection and immunity 2003;71(3):1352-60.
2003: Eileen M Barry; Zeev Altboum; Genevieve A Losonsky; Myron M Levine
Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.
Vaccine 2003;21(5-6):333-40.
2002: Fernando Ruiz-Perez; Rocío León-Kempis; Araceli Santiago-Machuca; Guadalupe Ortega-Pierres; Eileen M Barry; Myron M Levine; César González-Bonilla
Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL.
Infection and immunity 2002;70(7):3611-20.
2001: Zeev Altboum; Eileen M Barry; Genevieve A Losonsky; James E Galen; Myron M Levine
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Infection and immunity 2001;69(5):3150-8.
2000: H Koprowski; Myron M Levine; RJ Anderson; Genevieve A Losonsky; M Pizza; Eileen M Barry
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
Infection and immunity 2000;68(9):4884-92.
2000: Jin Yuan Wang; FR Noriega; James E Galen; Eileen M Barry; Myron M Levine
Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
Infection and immunity 2000;68(8):4647-52.
2000: Karen L Kotloff; FR Noriega; T Samandari; Marcelo B Sztein; Genevieve A Losonsky; James P Nataro; William D Picking; Eileen M Barry; Myron M Levine
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.
Infection and immunity 2000;68(3):1034-9.
1997: Myron M Levine; James E Galen; Eileen M Barry; FR Noriega; Carol O Tacket; Marcelo B Sztein; Steven N Chatfield; Gordon Dougan; Genevieve A Losonsky; Karen L Kotloff
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Behring Institute Mitteilungen 1997;(98):120-3.
1996: Augusto A. Franco-Mora; P E Yeh; Judith A Johnson; Eileen M Barry; Humberto Guerra; R Maurer; J Glenn Morris
Cloning and characterization of dnaE, encoding the catalytic subunit of replicative DNA polymerase III, from Vibrio cholerae strain C6706.
Gene 1996;175(1-2):281-3.
1996: Eileen M Barry; OG Gómez-Duarte; Steven N Chatfield; R Rappuoli; Mariagrazia Pizza; Genevieve A Losonsky; James E Galen; Myron M Levine
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
Infection and immunity 1996;64(10):4172-81.
1996: Alexander Sulakvelidze; K Dalakishvili; Eileen M Barry; G Wauters; Roy M Robins-Browne; P Imnadze; J Glenn Morris
Analysis of clinical and environment Yersinia isolates in the Republic of Georgia.
Journal of clinical microbiology 1996;34(9):2325-7.
1996: Myron M Levine; James E Galen; Eileen M Barry; FR Noriega; Steven N Chatfield; Marcelo B Sztein; Gordon Dougan; Carol O Tacket
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
Journal of biotechnology 1996;44(1-3):193-6.
1993: Erik L Hewlett; Mary C Gray; I E Ehrmann; N J Maloney; AS Otero; L Gray; M Allietta; Gabor Szabo; A A Weiss; Eileen M Barry
Characterization of adenylate cyclase toxin from a mutant of Bordetella pertussis defective in the activator gene, cyaC.
The Journal of biological chemistry 1993;268(11):7842-8.
1992: I E Ehrmann; A A Weiss; M S Goodwin; Mary C Gray; Eileen M Barry; Erik L Hewlett
Enzymatic activity of adenylate cyclase toxin from Bordetella pertussis is not required for hemolysis.
FEBS letters 1992;304(1):51-6.
1991: Eileen M Barry; A A Weiss; I E Ehrmann; Mary C Gray; Erik L Hewlett; M S Goodwin
Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation.
Journal of bacteriology 1991;173(2):720-6.